TY  - CONF
AU  - Marković, Srđan
AU  - Kralj, Đorđe
AU  - Odanović, Olga
AU  - Homšek, Ana
AU  - Kalaba, Ana
AU  - Svorcan, Petar
AU  - Vučićević, Katarina
PY  - 2023
UR  - https://farfar.pharmacy.bg.ac.rs/handle/123456789/4828
PB  - Oxford Academic Press
C3  - Journal of Crohn's and Colitis
T1  - Pharmacokinetics and clinical evaluation of vedolizumab based on real-life routine monitoring data in IBD patients
VL  - 17
IS  - Supplement 1
SP  - i925
EP  - i925
DO  - 10.1093/ecco-jcc/jjac190.0922
ER  - 

@conference{
author = "Marković, Srđan and Kralj, Đorđe and Odanović, Olga and Homšek, Ana and Kalaba, Ana and Svorcan, Petar and Vučićević, Katarina",
year = "2023",
publisher = "Oxford Academic Press",
journal = "Journal of Crohn's and Colitis",
title = "Pharmacokinetics and clinical evaluation of vedolizumab based on real-life routine monitoring data in IBD patients",
volume = "17",
number = "Supplement 1",
pages = "i925-i925",
doi = "10.1093/ecco-jcc/jjac190.0922"
}

Marković, S., Kralj, Đ., Odanović, O., Homšek, A., Kalaba, A., Svorcan, P.,& Vučićević, K.. (2023). Pharmacokinetics and clinical evaluation of vedolizumab based on real-life routine monitoring data in IBD patients. in Journal of Crohn's and Colitis
Oxford Academic Press., 17(Supplement 1), i925-i925.
https://doi.org/10.1093/ecco-jcc/jjac190.0922

Marković S, Kralj Đ, Odanović O, Homšek A, Kalaba A, Svorcan P, Vučićević K. Pharmacokinetics and clinical evaluation of vedolizumab based on real-life routine monitoring data in IBD patients. in Journal of Crohn's and Colitis. 2023;17(Supplement 1):i925-i925.
doi:10.1093/ecco-jcc/jjac190.0922 .

Marković, Srđan, Kralj, Đorđe, Odanović, Olga, Homšek, Ana, Kalaba, Ana, Svorcan, Petar, Vučićević, Katarina, "Pharmacokinetics and clinical evaluation of vedolizumab based on real-life routine monitoring data in IBD patients" in Journal of Crohn's and Colitis, 17, no. Supplement 1 (2023):i925-i925,
https://doi.org/10.1093/ecco-jcc/jjac190.0922 . .